INS and type 1 diabetes mellitus: INS/DFAN also exhibited high encapsulation efficiency, excellent stability, and enhanced insulin delivery, whereas in vivo experiments on type 1 diabetic rats demonstrated improved hypoglycaemic effects and improved insulin bioavailability over INS/FAN.